Activation of B lymphocytes: Integrating signals from CD19, CD22 and FcγRIIb1

Current Opinion in Immunology

Volumn 8, Issue 3, 1996, Pages 378-382

  Doody, Gina M ^a   Dempsey, Paul W ^a   Fearon, Douglas T ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; CD19 ANTIGEN; CD22 ANTIGEN; CYTOPLASM PROTEIN; FC RECEPTOR; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; LYMPHOCYTE MEMBRANE RECEPTOR; MEMBRANE PROTEIN;

ANTIBODY RESPONSE; APOPTOSIS; B LYMPHOCYTE ACTIVATION; B LYMPHOCYTE DIFFERENTIATION; LYMPHOID ORGAN; NONHUMAN; PROTEIN BINDING; PROTEIN DOMAIN; SHORT SURVEY; SIGNAL TRANSDUCTION;

EID: 0030176019     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-7915(96)80128-2     Document Type: Article

References (47)

1. Fearon DT, Carter RH. The CD19/CR2/TAPA-1 complex of B lymphocytes: linking natural to acquired immunity. Annu Rev Immunol. 13:1995;127-150.
2. Tedder TF, Zhou LJ, Engel P. The CD19/CD21 signal transduction complex of B lymphocytes. Immunol Today. 15:1994;437-442.
3. Van Noesel CJM, Lankester AC, Van Schijndel GMW, Van Lier RAW. The CD2/CD19 complex on human B cells contains the src-family kinase Lyn. Int Immunol. 5:1993;699-705.
4. Chalupny NJ, Aruffo A, Esselstyn JM, Chan P-Y, Bajorath J, Blake J, Gilliland LK, Ledbetter JA, Tepper MA. Specific binding of fyn and phosphatidylinositol 3-kinase to the B cell surface glycoprotein CD19 through their src homology 2 domains. Eur J Immunol. 25:1995;2978-2984.
5. Billips LG, Nuñez CA, Bertrand FE, Stankovic AK, Gartland GL, Burrows PD, Cooper MD. Immunoglobulin recombinase gene activity is modulated reciprocally by interleukin 7 and CD19 in B cell progenitors. of special interest J Exp Med. 182:1995;973-982 This study suggests that signals generated by CD19 and the IL-7 receptor may regulate rearrangement of gene fragments. Purified human pro-B cells treated in vitro with IL-7 downregulate TdT, RAG1 and RAG2. CD19 reverses the downregulation of RAG1 and RAG2.
6. Wolf ML, Weng W-K, Stieglbauer N, Shah N, LeBien TW. Functional effect of IL-7-enhanced CD19 expression on human B cell precursors. J Immunol. 151:1993;138-148.
7. Rickert RC, Rajewsky K, Roes J. Impairment of T-cell-dependent B-cell responses and B-1 cell development in CD19-deficient mice. of outstanding interest Nature. 376:1995;352-355 This paper, along with [8], demonstrates the important biologic role for CD19 in vivo. Disruption of the CD19 gene by homologous targeted recombination results in diminished numbers of B-1a cells and impaired responses to T cell-dependent antigens.
8. Engel P, Zhou L-J, Ord DC, Sato S, Koller B, Tedder TF. Abnormal B lymphocyte development, activation, and differentiation in mice that lack or overexpress the CD19 signal transduction molecule. of outstanding interest Immunity. 3:1995;39-50 See annotation [7].
9. Zhou LJ, Smith HM, Waldschmidt TJ, Schwarting R, Daley J, Tedder TF. Tissue-specific expression of human CD19 gene in transgenic mice inhibits antigen-independent B-lymphocyte development. Mol Cell Biol. 14:1994;3884-3894.
10. Krop I, De Fougerolles AR, Hardy RR, Allison M, Schissel MS, Fearon DT. Self-renewal of B-1 lymphocytes is dependent on CD19. Eur J Immunol. 26:1996;238-242.
11. null gene into mice deficient in RAG resulted in an absence of B-1 cells. The similarity of this effect to that of a deficiency in CD19 supports the demonstration of a functional interaction between Vav and CD19 and a role for CD19-mediated signaling in B-1 cells.
12. Tarakhovsky A, Turner M, Schaal S, Mee PJ, Duddy LP, Rajewsky K, Tybulewicz VLJ. Defective antigen receptor-mediated proliferation of B and T cells in the absence of Vav. of outstanding interest Nature. 374:1995;467-470 See annotation [11].
13. Weng WK, Jarvis L, LeBien TW. Signalling through CD19 activates a Vas/mitogen-activated protein kinase pathway and induces formation of a CD19/phosphatidylinositol 3-kinase complex in human B cell precursors. J Biol Chem. 263:1994;32514-32521.
14. Sato S, Steeba DA, Tedder TF. The Cd19 signal transduction molecule is a response regulator of B-lymphocyte differentiation. Proc Natl Acad Sci USA. 92:1995;11558-11562.
15. Behr S, Schriever F. Engaging CD19 or the target of an antiproliferative antibody 1 on human B lymphocytes induces binding of B cells to the interfollicular stroma of human tonsils via integrin α4β1 and fibronectin. J Exp Med. 182:1995;1191-1199.
16. Maloney MD, Lingwood CA. CD19 has a potential CD77 (Globotriasoyl ceramide)-binding site with sequence similarity to verotoxin B-subunits: implications of molecular mimicry for B cell adhesion and enterohemorrhagic Escherichia coli pathogenesis. J Exp Med. 180:1994;191-201.
17. Croix DA, Aheam JM, Rosengard AM, Han S, Kelsoe G, Ma M, Carroll MC. Antibody response to a T-dependent antigen requires B cell expression of complement receptors. J Exp Med. 183:1996;1857-1864.
18. Luxembourg AT, Cooper NR. Modulation of signalling via the B cell antigen receptor by CD21, the receptor for C3dg and EBV. J Immunol. 153:1994;4448-4457.
19. Kozono Y, Duke RC, Schleicher MS, Holers VM. Co-ligation of mouse complement receptors 1 and 2 with surface IgM rescues splenic B cells and WEHI-231 cells from anti-surface IgM-induced apoptosis. Eur J Immunol. 25:1995;1013-1017.
20. Dempsey PW, Allison MED, Akkaraju S, Goodnow CC, Fearon DT. C3d of complement as a molecular adjuvant: bridging innate and acquired immunity. of outstanding interest Science. 271:1996;348-350 A physiologic ligand for the CD19-CD21 complex relies on the intersection between innate and acquired immunity. Targeting the antigen HEL to this complex with the CD21 ligand C3d enhances the potency of the antigen by two to three orders of magnitude both in vitro and in vivo.
21. Uckun FM, Evans WE, Forsyth CJ, Waddick KG, Ahlgren LT, Chelstrom LM, Burkhardt A, Boden J, Myers DE. Biotherapy of B-cell precursor leukemia by targeting genistein to CD19-associated tyrosine kinases. Science. 267:1995;886-891.
22. Myers DE, Jun X, Waddick KG, Forsyth CJ, Chelstrom LM, Gunther RL, Turner NE, Bolen J, Uckun FM. Membrane-associated CD19-LYN complex is an endogenous p53-independent and Bcl-2 independent regulator of apoptosis in human B-lineage lymphoma cells. Proc Natl Acad Sci USA. 92:1995;9575-9579.
23. Leprince C, Draves KE, Geahlen RL, Ledbetter JA, Clark EA. CD22 associates with the human surface IgM-B-cell antigen receptor complex. J Immunol. 90:1993;3236-3240.
24. Wienands J, Freuler F, Baumann G. Tyrosine-phosphorylated forms of Igβ, CD22, TCRζ and HOSS are major ligands for tandem SH2 domains of Syk. Int Immunol. 7:1995;1701-1708.
25. Peaker CJG, Neuberger MS. Association of CD22 with the B-cell antigen receptor. Eur J Immunol. 23:1993;1359-1364.
26. Doody GD, Justement LB, Delibrias CC, Matthews RJ, Lin J, Thomas ML, Fearon DT. A role in B cell activation for CD22 and the protein tyrosine phosphatase SHP. of special interest Science. 269:1995;242-244 This paper describes the functional association of CD22 with the tyrosine phosphatase SHP and the augmentation of antigen receptor signaling following ligation of CD22. See also [27].
27. of outstanding interest Campbell MA, Kinman NR. Phosphotyrosine-dependent association between CD22 and protein tyrosine phosphatase. of outstanding interest Eur J Immunol. 25:1995;1573-1579 See annotation [26].
28. of special interest Okumura M, Thomas ML. Regulation of immune function by protein tyrosine phosphatases. Curr Opin Immunol. 7:1995;312-319.
29. Cyster JG, Goodnow CC. Protein tyrosine phosphatase 1C negatively regulates antigen receptor signaling in B lymphocytes and determines thresholds for negative selection. of outstanding interest Immunity. 2:1995;13-24 These authors show that the deficiency of SHP in motheaten viable mice resulted in hyperresponsive signaling through membrane immunoglobulin, indicating the negative regulatory role of this phosphatase.
30. Carter RH, Fearon DT. CD19: lowering the threshold for antigen receptor stimulation of B lymphocytes. Science. 256:1992;105-107.
31. Pezzutto A, Rabinovitch PS, Dörken B, Moldenhauer G, Clark EA. Role of the CD22 human B cell antigen in B cell triggering by anti-immunoglobulin. J Immunol. 140:1988;1791-1795.
32. Powell L, Varki A. The oligosaccharide binding specificities of CD22, β, a sialic-acid-specific lectin of B cells. J Biol Chem. 269:1994;10628-10636.
33. Powell LD, Jain RK, Matta KL, Sabesan S, Varki A. Characterization of sialyloligossacharide binding by recombinant soluble and native cell-associated CD22. J Biol Chem. 270:1995;7523-7532.
34. Hanasaki K, Varki A, Powell LD. CD22-mediated cell adhesion to cytokine-activated human endothelial cells. J Biol Chem. 270:1995;7533-7542.
35. Hanasaki K, Varki A, Stamenkovic I, Bevilacqua MP. Cytokine-induced β-galactoside α-2,6-sialyltransferase in human endothelial cells mediates α2,6-sialylation of adhesion molecules and CD22 molecules. J Biol Chem. 269:1994;10637-10643.
36. Engel P, Wagner N, Miller AS, Tedder TF. Identification of the ligand-binding domains of CD22, a member of the immunoglobulin superfamily that uniquely binds a sialic acid-dependent ligand. J Exp Med. 181:1995;1581-1586.
37. Hanasaki K, Powell LD, Varki A. Binding of human plasma sialoglycoproteins by the B cell-specific lectin CD22. J Biol Chem. 270:1995;7543-7550.
38. Sjoberg ER, Powell LD, Klein A, Varki A. Natural ligands of the B cell adhesion molecule CD22βcan be masked by 9-O-acetylation of sialic acids. J Cell Biol. 126:1994;549-562.
39. Braesch-Andersen S, Stamenkovic I. Sialylation of the B lymphocyte molecule CD22 by α2,6-sialyltransferase is implicated in the regulation of CD22-mediated adhesion. J Biol Chem. 269:1994;11783-11786.
40. Kelm S, Pelz A, Schauer R, Filbin MT, Tang S, De Bellard M-E, Schnaar RL, Mahoney JA, Hartnell A, Bradfield P, Crocker PR. Sialoadhesin, myelin-associated glycoprotein and CD22 define a new family of sialic acid-dependent adhesion molecules of the immunoglobulin superfamily. Curr Biol. 4:1994;965-972.
41. Takai T, Ono M, Hikida M, Ohmori H, Ravetch JV. Augmented humoral and anaphylactic responses in FcγRII-deficient mice. of special interest Nature. 379:1996;346-349 Analysis of FcγRII-deficient mice confirmed the negative regulatory role of this receptor in immune complex initiated signaling.
42. Choquet D, Partiseti M, Amigorena S, Bonnerot C, Fridman WH, Kom H. Cross-linking of IgG receptors inhibits membrane immunoglobulin-stimulated calcium influx in B lymphocytes. J Cell Biol. 121:1993;355-363.
43. Muta T, Kurosaki T, Misulovin Z, Sanchez M, Nussenzweig MC, Ravetch JV. A 13-amino-acid motif in the cytoplasmic domain of FcγRIIb modulates B-cell receptor signaling. of outstanding interest Nature. 368:1994;70-73 Dissection of FcγRIIb revealed that a single tyrosine residue mediates the negative modulation of membrane immunoglobulin signaling by FcγRIIb.
44. 2+ mobilization and B-cell proliferation following co-ligation of membrane immunoglobulin with FcγRIIb1.
45. Budde P, Bewarder N, Weinrich V, Schulzeck O, Frey J. Tyrosine-containing sequence motifs of the human immunoglobulin G receptors FcRIIb1 and FcRIIb2 essential for endocytosis and regulation of calcium in B cells. J Biol Chem. 269:1994;30636-30644.
46. 2+ from extracellular sources following membrane immunoglobulin ligation.
47. Aubry JP, Pochon S, Gauchat JF, Nueda-Marin A, Holers VM, Graber P, Siegfried C, Bonnefoy JY. CD23 interacts with a new functional extracytoplasmic domain involving N-linked oligosaccharides on CD21. J Immunol. 152:1994;5806-5813.